We are live on ! Find out more
RGLS

Regulus Therapeutics
RGLS

Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

51 hedge funds and large institutions have $134M invested in Regulus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

59% more capital invested

Capital invested by funds: $84M → $134M (+$49.9M)

31% more funds holding

Funds holding: 39 → 51 (+12)

Holders
51
Holders Change
+12
Holders Change %
+30.77%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
21
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$21.8M
2
HM
HealthCor Management
New York
+$9.59M
3
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$8.85M
4
Jennison Associates
Jennison Associates
New York
+$3.52M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.62M

Top Sellers

1
EA
Emerald Advisers
Pennsylvania
-$2.4M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$1.35M
3
Morgan Stanley
Morgan Stanley
New York
-$393K
4
SIM
Spark Investment Management
New York
-$347K
5
BI
BVF Inc
California
-$322K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10 +$1.18K +1 +13%
Morgan Stanley
52
Morgan Stanley
New York
– -$393K -334 Closed
SIM
53
Spark Investment Management
New York
– -$347K -296 Closed
PAM
54
Panagora Asset Management
Massachusetts
– -$213K -181 Closed
1 2
3